Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04550845 | Understanding of Genetics by Men at Risk for Prostate Cancer | recruiting | N/A | 90 | Mayo ClinicOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT07071207 | Effect of Text Message Reminders on M-ISI Score After Prostate Surgery(TextMsgM-ISI) | recruiting | N/A | 132 | University of RochesterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT |
| recruiting |
| Phase 1 |
| 30 |
| Brigham and Women's HospitalOTHER |
| 1 |
| Nov 5, 2025 |
| clinicaltrials |
| NCT06659614 | Prostate Tissue BioBank(PTBB) | recruiting | — | 200 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT07219303 | Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer(DE-CART) | recruiting | N/A | 80 | Fox Chase Cancer CenterOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT07222436 | Circulating Tumor DNA in High Risk Localized Prostate Cancer | recruiting | — | 24 | University of PittsburghOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT05919329 | Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy | recruiting | Phase 4 | 80 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 24, 2025 | clinicaltrials |
| NCT06165302 | Exercise in Prostate Cancer | recruiting | N/A | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 20, 2025 | clinicaltrials |
| NCT06141993 | ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials(ARCTIC) | recruiting | — | 120 | Duke UniversityOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT06960291 | Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada(EXCEL) | recruiting | N/A | 740 | University of CalgaryOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07141121 | Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen(IMARHGIN) | recruiting | N/A | 78 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07209878 | 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI | recruiting | Phase 2 / Phase 3 | 100 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT05869682 | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy | recruiting | Phase 2 | 210 | City of Hope Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT06433349 | A Multi-center Investigation of Family Health. | recruiting | — | 240 | Odense University HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05603559 | 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer | recruiting | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT06517901 | Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer(FOCUS-PC) | recruiting | N/A | 1,306 | Albany Medical CollegeOTHER | 2 | Oct 3, 2025 | clinicaltrials |
| NCT05346848 | Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer(DARIUS) | recruiting | Phase 2 | 62 | Institut BergoniéOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06824818 | Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients | recruiting | N/A | 155 | University of ChicagoOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations(GENPROS) | recruiting | — | 4,260 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06817668 | Evaluating Tolerability of ePUHRT With Brachytherapy Boost | recruiting | N/A | 31 | Indiana UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT07055165 | Connect2Care: Prostate Cancer Education and Screenings for African American Men | recruiting | N/A | 466 | University of OklahomaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT05324332 | 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05974774 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | recruiting | Phase 3 | 1,600 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 19, 2025 | clinicaltrials |
| NCT07179783 | Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC) | recruiting | Phase 2 | 28 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT04858880 | Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.(PROPER2) | recruiting | N/A | 374 | Lund University HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT07172685 | Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC | recruiting | N/A | 116 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT03678025 | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | recruiting | Phase 3 | 1,273 | SWOG Cancer Research NetworkNETWORK | 5 | Sep 11, 2025 | clinicaltrials |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | recruiting | Phase 1 | 345 | Nurix Therapeutics, Inc.INDUSTRY | 2 | Sep 9, 2025 | clinicaltrials |
| NCT05600400 | Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer(iSMART) | recruiting | N/A | 144 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05786742 | Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.(HYPO-5) | recruiting | N/A | 205 | CHU de Quebec-Universite LavalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06815354 | Comprehensive Assessment of Cancer Theranostic Response(TRAQinform) | recruiting | N/A | 32 | AIQ SolutionsINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07162987 | Prehabilitation to Patients With Prostate Cancer(PREPP) | recruiting | N/A | 20 | Odense University HospitalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06687421 | Implementation of Precision Medicine in High-risk Prostate Cancer(SPRINTR-REAL) | recruiting | — | 5,500 | Andreas JosefssonOTHER_GOV | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06689163 | A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone | recruiting | Phase 1 / Phase 2 | 66 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07149831 | A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults | recruiting | Phase 1 | 6 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06331013 | CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr(PRO-SPEED) | recruiting | N/A | 60 | European Institute of OncologyOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06134232 | Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T(ProvONE) | recruiting | Phase 2 | 400 | DendreonINDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06241846 | A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC | recruiting | Phase 2 | 100 | MediLink Therapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06683846 | Ivonescimab in the Treatment of Multiple Advanced Tumors | recruiting | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT05802121 | Akkermansia Muciniphilia and Metabolic Side Effects of ADT | recruiting | Early Phase 1 | 30 | Western UniversityOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07015138 | Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer(PROLONG-3) | recruiting | N/A | 390 | Peking University First HospitalOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07130708 | Exploring the Potential of Robotic Telesurgery in Remote Settings | recruiting | N/A | 10 | AdventHealthOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07112781 | Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer(FAST-ONE) | recruiting | N/A | 30 | Branch Office of "Hadassah Medical Ltd"OTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT06220435 | Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer | recruiting | N/A | 76 | Region SkaneOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07118436 | Liquid Biopsy Under PSMA Radioligand Therapy(LOOPS) | recruiting | — | 100 | Wuerzburg University HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07115277 | Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer | recruiting | N/A | 121 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05885009 | Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)(HOPE-PROSTATE) | recruiting | — | 240 | SOLTI Breast Cancer Research GroupOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07101731 | Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy | recruiting | N/A | 30 | Bartın UnıversityOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT03830788 | Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy(TEMPOS) | recruiting | N/A | 240 | Center Eugene MarquisOTHER | 1 | Aug 1, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Nov 6, 2025source: clinicaltrials